205 related articles for article (PubMed ID: 11378612)
21. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
22. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.
Wilkens H; Guth A; König J; Forestier N; Cremers B; Hennen B; Böhm M; Sybrecht GW
Circulation; 2001 Sep; 104(11):1218-22. PubMed ID: 11551870
[TBL] [Abstract][Full Text] [Related]
23. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
24. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
Klein A; Zils U; Bopp C; Gries A; Martin E; Gust R
J Surg Res; 2007 Apr; 138(2):224-30. PubMed ID: 17275845
[TBL] [Abstract][Full Text] [Related]
25. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).
Suntharalingam J; Hughes RJ; Goldsmith K; Doughty N; George P; Toshner M; Sheares KK; Pepke-Zaba J
Vascul Pharmacol; 2007 Jun; 46(6):449-55. PubMed ID: 17368113
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J
Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741
[TBL] [Abstract][Full Text] [Related]
27. Site-specific effect of guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition in isolated lamb lungs.
Steinhorn RH; Gordon JB; Tod ML
Crit Care Med; 2000 Feb; 28(2):490-5. PubMed ID: 10708189
[TBL] [Abstract][Full Text] [Related]
28. Therapy of pulmonary hypertension: targeting pathogenic mechanisms with selective treatment delivery.
Rubin LJ
Crit Care Med; 2001 May; 29(5):1086-7. PubMed ID: 11378627
[No Abstract] [Full Text] [Related]
29. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F
Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213
[TBL] [Abstract][Full Text] [Related]
30. Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep.
Booke M; Bradford DW; Hinder F; Harper D; Brauchle RW; Traber LD; Traber DL
Crit Care Med; 1996 Nov; 24(11):1841-8. PubMed ID: 8917035
[TBL] [Abstract][Full Text] [Related]
31. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
[TBL] [Abstract][Full Text] [Related]
32. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide inhalation: effects on the ovine neonatal pulmonary and systemic circulations.
DeMarco V; Skimming JW; Ellis TM; Cassin S
Reprod Fertil Dev; 1996; 8(3):431-8. PubMed ID: 8795107
[TBL] [Abstract][Full Text] [Related]
34. Effects of sildenafil on hypoxic pulmonary vascular function in dogs.
Fesler P; Pagnamenta A; Rondelet B; Kerbaul F; Naeije R
J Appl Physiol (1985); 2006 Oct; 101(4):1085-90. PubMed ID: 16778005
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep.
Deruelle P; Grover TR; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L798-806. PubMed ID: 15964898
[TBL] [Abstract][Full Text] [Related]
36. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children.
Namachivayam P; Theilen U; Butt WW; Cooper SM; Penny DJ; Shekerdemian LS
Am J Respir Crit Care Med; 2006 Nov; 174(9):1042-7. PubMed ID: 16917115
[TBL] [Abstract][Full Text] [Related]
37. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery.
Stocker C; Penny DJ; Brizard CP; Cochrane AD; Soto R; Shekerdemian LS
Intensive Care Med; 2003 Nov; 29(11):1996-2003. PubMed ID: 14530859
[TBL] [Abstract][Full Text] [Related]
38. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
39. Sildenafil treatment of primary pulmonary hypertension.
Laupland KB; Helmersen D; Zygun DA; Viner SM
Can Respir J; 2003; 10(1):48-50. PubMed ID: 12624621
[TBL] [Abstract][Full Text] [Related]
40. Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets.
Binns-Loveman KM; Kaplowitz MR; Fike CD
Pediatr Pulmonol; 2005 Jul; 40(1):72-80. PubMed ID: 15880376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
